Bryn Mawr Trust Advisors LLC Trims Holdings in UnitedHealth Group Incorporated $UNH

Bryn Mawr Trust Advisors LLC lessened its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 4.8% in the 2nd quarter, according to its most recent filing with the SEC. The fund owned 28,789 shares of the healthcare conglomerate’s stock after selling 1,460 shares during the period. Bryn Mawr Trust Advisors LLC’s holdings in UnitedHealth Group were worth $8,981,000 at the end of the most recent quarter.

Other institutional investors also recently bought and sold shares of the company. Pekin Hardy Strauss Inc. increased its stake in UnitedHealth Group by 4.1% during the 2nd quarter. Pekin Hardy Strauss Inc. now owns 3,231 shares of the healthcare conglomerate’s stock worth $1,008,000 after buying an additional 128 shares during the period. Texas Yale Capital Corp. raised its stake in shares of UnitedHealth Group by 161.7% in the second quarter. Texas Yale Capital Corp. now owns 6,587 shares of the healthcare conglomerate’s stock valued at $2,055,000 after acquiring an additional 4,070 shares in the last quarter. Soltis Investment Advisors LLC grew its stake in UnitedHealth Group by 30.6% during the 2nd quarter. Soltis Investment Advisors LLC now owns 27,465 shares of the healthcare conglomerate’s stock worth $8,568,000 after purchasing an additional 6,437 shares in the last quarter. Yacktman Asset Management LP acquired a new stake in UnitedHealth Group in the 2nd quarter valued at about $40,244,000. Finally, Washington Trust Bank grew its position in shares of UnitedHealth Group by 1.9% during the second quarter. Washington Trust Bank now owns 31,569 shares of the healthcare conglomerate’s stock worth $9,849,000 after buying an additional 577 shares in the last quarter. 87.86% of the stock is owned by institutional investors and hedge funds.

UnitedHealth Group Price Performance

UNH stock opened at $321.68 on Friday. The business has a 50 day simple moving average of $345.55 and a 200-day simple moving average of $324.07. The company has a market capitalization of $291.39 billion, a P/E ratio of 16.79, a PEG ratio of 2.28 and a beta of 0.47. UnitedHealth Group Incorporated has a twelve month low of $234.60 and a twelve month high of $630.73. The company has a current ratio of 0.82, a quick ratio of 0.85 and a debt-to-equity ratio of 0.71.

UnitedHealth Group (NYSE:UNH) last issued its quarterly earnings results on Tuesday, October 28th. The healthcare conglomerate reported $2.92 earnings per share for the quarter, topping analysts’ consensus estimates of $2.87 by $0.05. UnitedHealth Group had a net margin of 4.04% and a return on equity of 19.23%. The firm had revenue of $113.16 billion during the quarter, compared to analysts’ expectations of $113.19 billion. During the same quarter in the prior year, the business earned $7.15 EPS. UnitedHealth Group’s quarterly revenue was up 12.2% compared to the same quarter last year. As a group, equities analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. This represents a $8.84 annualized dividend and a dividend yield of 2.7%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio (DPR) is 46.14%.

Analysts Set New Price Targets

Several research firms have commented on UNH. Oppenheimer lowered their price target on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a report on Wednesday, July 30th. Robert W. Baird reissued an “underperform” rating and issued a $198.00 target price (down previously from $312.00) on shares of UnitedHealth Group in a report on Thursday, July 31st. Sanford C. Bernstein upped their price objective on UnitedHealth Group from $433.00 to $440.00 and gave the stock an “outperform” rating in a research report on Thursday, October 30th. Cantor Fitzgerald reissued an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Finally, Wells Fargo & Company raised their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the stock an “overweight” rating in a report on Tuesday, October 7th. Eighteen research analysts have rated the stock with a Buy rating, nine have assigned a Hold rating and three have given a Sell rating to the stock. Based on data from MarketBeat, UnitedHealth Group currently has a consensus rating of “Moderate Buy” and an average target price of $397.12.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.